Advancing life sciences through multi-omics innovation, we deliver end-to-end solutions for drug development and clinical diagnostics, spanning the continuum from discovery research to clinical translation. Backed by advanced technology platforms, a quality management system compliant with GLP, GCP, CLIA, and other industry standards, and a dedicated team of technical experts, we offer more than 300 testing services across genomics, transcriptomics, proteomics, and single-cell and spatial multi-omics. Our integrated solutions support critical stages of the R&D process, including target identification and drug discovery, patient stratification and companion diagnostics, efficacy and safety assessment, and drug resistance mechanism studies, enabling data-driven decision-making from preclinical research and clinical trials to post-marketing real-world studies. By combining multi-omics technologies with translational research, we accelerate innovation and advance precision medicine.

Sequanta delivers comprehensive multi-omics services and tailored solutions spanning disease mechanism research, novel biomarker discovery, clinical trial support, and companion diagnostic development, enabling clients to generate actionable insights by leveraging exceptional data quality, scientific rigor, and a flexible collaborative approach.